NCT07259213
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07259213
Title A Study of Terbium 161 (161Tb)-RAD402 in Participants With CRPC (RAD402)
Acronym RAD402
Recruitment Recruiting
Gender male
Phase Phase Ib/II
Variant Requirements No
Sponsors Radiopharm Theranostics, Ltd
Indications
Therapies
Age Groups: senior | adult
Covered Countries AUS

Facility Status City State Zip Country Details
Wollongong Hospital RECRUITING Wollongong New South Wales 2500 Australia Details
Icon Cancer Centre Hollywood RECRUITING Nedlands Western Australia 6009 Australia Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field